N | Arg vs. Pro | ArgArg vs. ProPro | ArgPro vs. ProPro | (ArgPro + ArgArg) vs. ProPro | ArgArg vs. (ProPro + ArgPro) | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|
OR (95% CI) | I2(%) | OR (95% CI) | I2(%) | OR (95% CI) | I2(%) | OR (95% CI) | I2(%) | OR (95% CI) | I2(%) | ||
Overall | 11 | 0.77(0.48-1.22) | 96 | 0.67 (0.31-1.43) | 94 | 1.14 (0.97-1.35) | 0 | 0.85 (0.53-1.34) | 87 | 0.64 (0.34-1.23) | 95 |
HPV status | |||||||||||
Without | 9 | 0.81 (0.48-1.39) | 97 | 0.75 (0.32-1.79) | 95 | 1.20 (1.01-1.43) | 0 | 0.93 (0.56-1.55) | 89 | 0.68 (0.32-1.42) | 96 |
With | 2 | 0.60 (0.43-0.85) | 0 | 0.41 (0.21-0.81) | 0 | 0.61 (0.33-1.14) | 0 | 0.54 (0.30-0.96) | 0 | 0.54 (0.32-0.91) | 0 |
Source of controls | |||||||||||
PB | 7 | 0.60 (0.26-1.38) | 98 | 0.43 (0.11-1.64) | 96 | 1.15 (0.92-1.44) | 0 | 0.71 (0.33-1.55) | 92 | 0.37 (0.12-1.19) | 96 |
HB | 5 | 1.03 (0.79-1.35) | 71 | 1.09 (0.64-1.87) | 69 | 1.13 (0.87-1.45) | 17 | 1.06 (0.73-1.53) | 52 | 1.22 (0.88-1.69) | 59 |
HWE | |||||||||||
>0.05 | 8 | 0.99 (0.82-1.20) | 70 | 1.03 (0.70-1.50) | 65 | 1.10 (0.91-1.32) | 0 | 1.08 (0.91-1.29) | 38 | 0.98 (0.73-1.31) | 69 |
<0.05 | 3 | 0.44 (0.08-2.44) | 99 | 0.27 (0.02-3.72) | 97 | 1.36 (0.92-2.00) | 0 | 0.61 (0.13-2.82) | 95 | 0.23 (0.02-2.70) | 98 |